George L. Sing - 25 Feb 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Issuer symbol
REGN
Transactions as of
25 Feb 2022
Net transactions value
-$2,473,000
Form type
4
Filing time
01 Mar 2022, 15:03:13 UTC
Previous filing
05 Jan 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,242,000 -2,000 -6.7% $621.00 28,049 25 Feb 2022 Direct
transaction REGN Common Stock Sale $614,000 -1,000 -3.6% $614.00 27,049 28 Feb 2022 Direct
transaction REGN Common Stock Sale $617,000 -1,000 -3.7% $617.00 26,049 28 Feb 2022 Direct
holding REGN Common Stock 750 25 Feb 2022 by Spouse
holding REGN Common Stock 400 25 Feb 2022 by Spouse/Cust Son
holding REGN Common Stock 1,000 25 Feb 2022 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.